FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W90094331> ?p ?o ?g. }

• W90094331 endingPage "30" @default.
• W90094331 startingPage "10" @default.
• W90094331 abstract "The in vivo micronucleus assay working group of the International Workshop on Genotoxicity Testing (IWGT) discussed new aspects in the in vivo micronucleus (MN) test, including the regulatory acceptance of data derived from automated scoring, especially with regard to the use of flow cytometry, the suitability of rat peripheral blood reticulocytes to serve as the principal cell population for analysis, the establishment of in vivo MN assays in tissues other than bone marrow and blood (for example liver, skin, colon, germ cells), and the biological relevance of the single-dose-level test. Our group members agreed that flow cytometric systems to detect induction of micronucleated immature erythrocytes have advantages based on the presented data, e.g., they give good reproducibility compared to manual scoring, are rapid, and require only small quantities of peripheral blood. Flow cytometric analysis of peripheral blood reticulocytes has the potential to allow monitoring of chromosome damage in rodents and also other species as part of routine toxicology studies. It appears that it will be applicable to humans as well, although in this case the possible confounding effects of splenic activity will need to be considered closely. Also, the consensus of the group was that any system that meets the validation criteria recommended by the IWGT (2000) should be acceptable. A number of different flow cytometric-based micronucleus assays have been developed, but at the present time the validation data are most extensive for the flow cytometric method using anti-CD71 fluorescent staining especially in terms of inter-laboratory collaborative data. Whichever method is chosen, it is desirable that each laboratory should determine the minimum sample size required to ensure that scoring error is maintained below the level of animal-to-animal variation. In the second IWGT, the potential to use rat peripheral blood reticulocytes as target cells for the micronucleus assay was discussed, but a consensus regarding acceptability for regulatory purposes could not be reached at that time. Subsequent validation efforts, combined with accumulated published data, demonstrate that blood-derived reticulocytes from rats as well as mice are acceptable when young reticulocytes are analyzed under proper assay protocol and sample size. The working group reviewed the results of micronucleus assays using target cells/tissues other than hematopoietic cells. We also discussed the relevance of the liver micronucleus assay using young rats, and the importance of understanding the maturation of enzyme systems involved in the processes of metabolic activation in the liver of young rats. Although the consensus of the group was that the more information with regard to the metabolic capabilities of young rats would be useful, the published literature shows that young rats have sufficient metabolic capacity for the purposes of this assay. The use of young rats as a model for detecting MN induction in the liver offers a good alternative methodology to the use of partial hepatectomy or mitogenic stimulation. Additional data obtained from colon and skin MN models have been integrated into the data bases, enhancing confidence in the utility of these models. A fourth topic discussed by the working group was the regulatory acceptance of the single-dose-level assay. There was no consensus regarding the acceptability of a single dose level protocol when dose-limiting toxicity occurs. The use of a single dose level can lead to problems in data interpretation or to the loss of animals due to unexpected toxicity, making it necessary to repeat the study with additional doses. A limit test at a single dose level is currently accepted when toxicity is not dose-limiting." @default.
• W90094331 created "2016-06-24" @default.
• W90094331 creator A5005409085 @default.
• W90094331 creator A5021440089 @default.
• W90094331 creator A5028042281 @default.
• W90094331 creator A5028167196 @default.
• W90094331 creator A5036645180 @default.
• W90094331 creator A5046109273 @default.
• W90094331 creator A5049534335 @default.
• W90094331 creator A5061323840 @default.
• W90094331 creator A5061445540 @default.
• W90094331 creator A5068200348 @default.
• W90094331 creator A5070698304 @default.
• W90094331 creator A5078914737 @default.
• W90094331 creator A5090776655 @default.
• W90094331 date "2007-02-01" @default.
• W90094331 modified "2023-10-17" @default.
• W90094331 title "In vivo erythrocyte micronucleus assay" @default.
• W90094331 cites W1493785014 @default.
• W90094331 cites W1563928419 @default.
• W90094331 cites W1583631644 @default.
• W90094331 cites W1590889826 @default.
• W90094331 cites W1642047822 @default.
• W90094331 cites W1963908638 @default.
• W90094331 cites W1964240097 @default.
• W90094331 cites W1966857419 @default.
• W90094331 cites W1967573143 @default.
• W90094331 cites W1968070609 @default.
• W90094331 cites W1968097822 @default.
• W90094331 cites W1969037254 @default.
• W90094331 cites W1972024729 @default.
• W90094331 cites W1976430549 @default.
• W90094331 cites W1977433776 @default.
• W90094331 cites W1977532310 @default.
• W90094331 cites W1977752260 @default.
• W90094331 cites W1979053663 @default.
• W90094331 cites W1980303697 @default.
• W90094331 cites W1980574038 @default.
• W90094331 cites W1981313286 @default.
• W90094331 cites W1981599622 @default.
• W90094331 cites W1981978118 @default.
• W90094331 cites W1986897901 @default.
• W90094331 cites W1988252528 @default.
• W90094331 cites W1989229340 @default.
• W90094331 cites W1989339166 @default.
• W90094331 cites W1992081700 @default.
• W90094331 cites W1992148435 @default.
• W90094331 cites W1992496982 @default.
• W90094331 cites W1994560538 @default.
• W90094331 cites W1994887637 @default.
• W90094331 cites W1995034541 @default.
• W90094331 cites W1995064185 @default.
• W90094331 cites W1996198612 @default.
• W90094331 cites W1997057158 @default.
• W90094331 cites W1999322869 @default.
• W90094331 cites W2000264645 @default.
• W90094331 cites W2000311307 @default.
• W90094331 cites W2002519505 @default.
• W90094331 cites W2004642777 @default.
• W90094331 cites W2005129448 @default.
• W90094331 cites W2006641412 @default.
• W90094331 cites W2006927103 @default.
• W90094331 cites W2007823219 @default.
• W90094331 cites W2007956308 @default.
• W90094331 cites W2009401108 @default.
• W90094331 cites W2012950645 @default.
• W90094331 cites W2014887559 @default.
• W90094331 cites W2014968991 @default.
• W90094331 cites W2017118757 @default.
• W90094331 cites W2023441751 @default.
• W90094331 cites W2025666347 @default.
• W90094331 cites W2026075744 @default.
• W90094331 cites W2028192512 @default.
• W90094331 cites W2030868241 @default.
• W90094331 cites W2032210410 @default.
• W90094331 cites W2033785453 @default.
• W90094331 cites W2033819842 @default.
• W90094331 cites W2039826013 @default.
• W90094331 cites W2039944337 @default.
• W90094331 cites W2040305737 @default.
• W90094331 cites W2040770719 @default.
• W90094331 cites W2044403610 @default.
• W90094331 cites W2044738335 @default.
• W90094331 cites W2046037038 @default.
• W90094331 cites W2046908575 @default.
• W90094331 cites W2052064846 @default.
• W90094331 cites W2052257509 @default.
• W90094331 cites W2052634735 @default.
• W90094331 cites W2053493344 @default.
• W90094331 cites W2055410909 @default.
• W90094331 cites W2056362421 @default.
• W90094331 cites W2057427612 @default.
• W90094331 cites W2057551186 @default.
• W90094331 cites W2060258936 @default.
• W90094331 cites W2060668370 @default.
• W90094331 cites W2066503107 @default.
• W90094331 cites W2068648707 @default.
• W90094331 cites W2069170671 @default.

• next